Abstract:Objective: The in vivo effects of anti-interleukin-6 (anti-IL-6) and anti-interleukin-6-alpha receptor (anti-IL-6R) monoclonal antibodies on immune response and survival rate of a burn with subsequent infection were assessed. Subjects: Ten-week-old C 57 BL/6J mice received a standardized contact burn; 48 hrs later endotoxin (LPS) was injected intraperitoneally to induce systemic inflammation. Ten different groups were studied. Groups I-IV sustained a burn and/or a LPS-stimulus but did not receive any anti-cytokines and served as controls. Treatment groups V-X sustained the same injuries but also received anti-IL-6 and anti-IL-6R intravenously either before or after the LPS stimulus. In a further part of the study, a lethal dose of LPS was injected (LPS-LD(100) group) followed by an injection of anti-IL-6 antibody and/or anti-IL-6R antibody. Measurements: Serum concentrations of IL-6, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and white blood cell and platelet counts were determined, and the survival rate over a 2-wk period was assessed. Results: Treatment with anti-IL-6 slightly decreased the inflammatory response when it was given before or after LPS application. The inflammatory response was not decreased after treatment with anti-IL-6R. In the groups that received a combination of anti-IL-6 and anti-IL-6R, there was a significant reduction of the inflammatory response. This was more pronounced when the anti-cytokines were applied after LPS application. A significant reduction in mortality could be shown with both antibodies in the treatment groups and the groups that had received a lethal dose of LPS (LPS-LD(100) group). Conclusions: IL-6 has a low inflammatory potential, and IL-6R has no inflammatory potential by itself. In contrast, the IL-6/IL-6R complexes have a higher inflammatory potential. Mortality could be reduced by each antibody alone as well as by the combination, supporting the hypothesis that the inflammatory and lethal potentials of IL-6 are not identical. The study suggests that the use of antibodies against IL-6 or IL-6R is effective in the prevention of systemic inflammation in a murine burn model.

Endogenous Interleukin-6 Plays A Crucial Protective Role In Streptococcal Toxic Shock Syndrome Via Suppression Of Tumor Necrosis Factor Alpha Production

Lipopolysaccharide Triggers Invasive Streptococcal Disease In Mice Through A Tumour Necrosis Factor-Alpha-Dependent Mechanism

Association of Tumor Necrosis Factor Α − 308G/A and Interleukin-6 − 174G/C Gene Polymorphism with Pneumonia-Induced Sepsis

Protective Role Of Nuclear Factor Erythroid 2-Related Factor 2 In The Hemorrhagic Shock-Induced Inflammatory Response

Tumor Necrosis Factor-α is Required for Mast Cell-Mediated Host Immunity Against Cutaneous Staphylococcus Aureus Infection.

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model

Regulation of IL-8 Production by Complement-Activated Product, C5a, in Vitro and in Vivo During Sepsis.

Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model

Superantigens and Streptococcal Toxic Shock Syndrome

The Therapeutic Effect of an Anti-TNF-α/HSA/IL-6R Triple-Specific Fusion Protein Under Experimental Septic Conditions

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

IL-18 Signaling Is Essential for Causing Streptococcal Toxic Shock-Like Syndrome (STSLS)

IL-6 Deficiency Attenuates Skeletal Muscle Atrophy by Inhibiting Mitochondrial ROS Production through the Upregulation of PGC-1α in Septic Mice

The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo

Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS

The Two-Faced Cytokine IL-6 in Host Defense and Diseases